Pharmagen(OTC) PHRX

Pharmagen, Inc. is a pharmaceutical company based in Silver Spring, Maryland, specializing in the distribution of specialty drugs within the U.S. healthcare market. The company provides a diverse range of medical products, including plasma derivatives, vaccines, and health supplements, catering to various healthcare practitioners nationwide.

Products and Services

• Distribution of specialty pharmaceuticals and blood plasma derivatives
• Production and sale of health supplements, including Clotamin
• Supply of traditional pharmaceuticals, such as antibiotics and vaccines

Growth Outlook

• Focus on expanding the specialty drug distribution network
• Increasing demand for plasma derivatives in chronic disease management
• Potential for growth in health supplement market with Clotamin

Financial Highlights

• Recent quarterly revenue of 1,319.464, showing growth from previous quarters
• Gross profit margin of 55.8% indicates strong product demand
• Current ratio of 0.11 suggests potential liquidity challenges

Pharmagen, Inc. operates in a critical sector of the healthcare industry, providing essential medications and health products. The company's focus on specialty pharmaceuticals and plasma derivatives positions it well to meet the growing needs of healthcare providers and patients. Recent financial data indicates a positive trend in revenue, reflecting the effectiveness of its distribution strategies. However, the current ratio suggests that liquidity may be a concern, warranting attention as the company continues to navigate its growth trajectory. The potential for expansion in both the specialty drug and health supplement markets presents opportunities for future development and profitability.